10-Year hepatitis study aims to unlock secrets of liver disease
NCT ID NCT02995252
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study follows people with chronic hepatitis B or C for up to 10 years to track how the disease changes over time. A smaller group with hepatitis B will receive the drug tenofovir alafenamide for 2 years to see if it reduces liver stiffness. Participants provide blood samples and may have optional liver biopsies or FibroScans.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tenofovir alafenamide
What this could lead to
If successful, this could help doctors better understand how hepatitis B and C progress over time and whether tenofovir alafenamide can reduce liver stiffness.
What could go wrong
This is an observational study with a small treatment sub-study, so results may not apply to everyone. The treatment may not improve liver health for all participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr Huong Dang, Medical Practice
Falls Church, Virginia, 22044, United States
-
Institute of Human Virology, University of Maryland School of Medicine
Baltimore, Maryland, 21201, United States